It is of interest that analyses from The Cancer Genome Atlas (TCGA) identified the TERT promoter to be a somatic mutation hotspot for melanoma and bladder cancer as well as glioblastoma, glioma, liver, medulloblastoma and lung cancer [21]. This evidence concerns the gene TERT and lung carcinoma.